NBRV Market Cap History



Below is a table of the NBRV market cap history going back to 7/15/2017:

Date NBRV Market Cap
7/15/2017282.34M
2/28/2018188.72M
4/30/2018193.47M
7/31/2018180.17M
10/26/2018138.65M
2/28/2019138.01M
4/30/2019216.95M
7/30/2019175.33M
7/23/201983.16M
10/31/2019151.22M
2/28/2020127.74M
4/30/202054.79M
7/31/2020109.30M
10/31/202074.78M
12/3/202056.84M
2/28/202159.81M
4/30/202163.05M
7/31/202154.71M
10/31/202162.46M
2/28/202227.48M
4/30/202219.78M
7/31/202211.91M
10/31/20227.78M
2/28/20235.73M
4/30/20235.12M

Also see: NBRV Shares Outstanding History
and NBRV YTD Return
NBRV Historical Market Cap:
-49.94% CAGR
NBRV Historical Market Cap: +-49.94% CAGR

Mouse over chart for data details
7/15/2017 ...4/30/2023
Nabriva Therapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company engaged in the research, development and commercialization of anti-infective agents to treat serious infections. Co. has approval from the U.S. Food and Drug Administration for XENLETA for the treatment of adults with community-acquired bacterial pneumonia. XENLETA is an oral and intravenous treatment in the pleuromutilin class of antibiotics available for the systematic administration in humans. Co.'s CONTEPO is a potentially epoxide antibiotic for intravenous use in the U.S. for complicated urinary tract infections. Co. may develop XENLETA and CONTEPO for additional indications. We show 25 historical shares outstanding datapoints in our NBRV shares outstanding history coverage, used to compute NBRV market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NBRV market cap history over the course of time is important for investors interested in comparing NBRV's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NBRV versus a peer is one thing; comparing NBRV market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NBRV can fluctuate over the course of history. With this page we aim to empower investors researching NBRV by allowing them to research the NBRV market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree NBRV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Nabriva Therapeutics (NBRV) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

NBST Market Cap History
NCAC Market Cap History
NCNA Market Cap History
NCNC Market Cap History
NDAC Market Cap History
NEBC Market Cap History
NEBU Market Cap History
NEGG Market Cap History
NESR Market Cap History
NETC Market Cap History
More Miscellaneous companies »

 

NBRV Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.